PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
11-Jun-2020 Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020 Bone Therapeutics
11-Jun-2020 Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies About Zelluna Immunotherapy
11-Jun-2020 Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in The New England Journal of Medicine Alnylam Pharmaceuticals, Inc.
10-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
08-Jun-2020 WORLD EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET RESEARCH REPORT 2025, COVID BUSINESS IMPACT INFORMATION COVERED The Holistic Reports
08-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
08-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
08-Jun-2020 AbbVie at EULAR - RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients AbbVie
08-Jun-2020 US FDA Grants Mexiletine Orphan Drug Designation Lupin
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica
08-Jun-2020 First adjuvanted quadrivalent influenza vaccine receives EU approval Seqirus
08-Jun-2020 Novo Holdings REPAIR Impact Fund Launches Global Call for New Investment Proposals to Fight AMR Novo Holdings
08-Jun-2020 Vectura signs agreement with Aerami Therapeutics Inc Vectura Group plc
08-Jun-2020 Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities Helsinn Group
05-Jun-2020 Calliditas Therapeutics prices its initial public offering on The Nasdaq Global Select Market in the United States Calliditas Therapeutics AB
05-Jun-2020 Herbert Smith Freehills advises Acacia on its acquisition of shares in up to 19 public and private life sciences companies Herbert Smith Freehills’
05-Jun-2020 Sosei Heptares notes Phase IIIb ARGON study with Enerzair® Breezhaler® (QVM149) meets primary endpoint in patients with uncontrolled asthma Sosei Group Corporation
04-Jun-2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels Hyloris Pharmaceuticals SA
04-Jun-2020 AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) AMRYT PHARMA PLC
04-Jun-2020 MARINOMED EXPANDS INTO ITALY AND BROADENS ITS PORTFOLIO Marinomed Biotech AG